Inhibitors of janus kinases and/or 3-phosphoinositide-dependent protein kinase-1
US8329722B2 · kind B2 · utility
0Cited by
1References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 10, 2008 |
| Grant date | Dec 11, 2012 |
| Priority date | — |
| Expiry date | Jun 5, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The instant invention provides for compounds that inhibit JAK2 tyrosine kinase and/or PDK1. The invention also provides for compositions comprising such inhibitory compounds and methods of inhibiting JAK2 tyrosine kinase activity and/or PDK1 kinase inhibitory activity by administering the compound to a patient in need of treatment or prevention of myeloproliferative disorders or cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.